Intracoronary reopro during percutaneous coronary intervention in acute and stable patient can influence stent thrombosis formation (IRPASST) study

Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration. Intracoronary (IC) bolus application of abciximab causes very high...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mohammed Balghith, Ali Al-Ghamdi, El harif Zain, Ahmed Al-Saileek
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wolters Kluwer Medknow Publications 2013-01-01
Edice:	Heart Views
Témata:	Abciximab acute coronary artery disease intracoronary intravenous stent thrombosis tirofiban
On-line přístup:	http://www.heartviews.org/article.asp?issn=1995-705X;year=2013;volume=14;issue=2;spage=62;epage=67;aulast=Balghith
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!